PROPHYLAXIS OF EXERCISE-INDUCED ASTHMA WITH INHALED FORMOTEROL, A LONG-ACTING BETA-2-ADRENERGIC AGONIST

被引：27
|
作者：
MCALPINE, LG
THOMSON, NC
机构：
[1] Department of Respiratory Medicine, Western Infirmary, Glasgow
来源：
RESPIRATORY MEDICINE | 1990年 / 84卷 / 04期
关键词：
D O I：
10.1016/S0954-6111(08)80056-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The prophylaxis of exercise-induced asthma with inhaled formoterol (12 μg) was compared with inhaled salbutamol (200 μg) and placebo in 12 patients with atopic asthma. Both drugs produced equal bronchodilation 2 and 4 h after administration. Both drugs protected equally against exercise-induced bronchoconstriction 2 h after administration; at 4 h, formoterol gave undiminished protection from that seen at 2 h while salbutamol was no more effective than placebo. © 1990, Baillière Tindall. All rights reserved.
引用
收藏
页码：293 / 295
页数：3
相关论文
共 50 条
  • [21] BITOLTEROL AND ALBUTEROL METERED-DOSE AEROSOLS - COMPARISON OF 2 LONG-ACTING BETA-2-ADRENERGIC BRONCHODILATORS FOR TREATMENT OF ASTHMA
    ORGEL, HA
    KEMP, JP
    TINKELMAN, DG
    WEBB, DR
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1985, 75 (01) : 55 - 62
  • [22] ANTIHYPERTENSIVE ACTIONS OF A LONG-ACTING BETA-ADRENERGIC AGONIST
    BITTNER, SE
    KRUEGER, A
    MOONEY, AK
    LIANG, CD
    WILLIAMS, K
    YANG, PC
    WALSH, GM
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 879 - 879
  • [23] Arformoterol -: The first nebulized long-acting beta2-adrenergic agonist
    Abdelghany, Osama
    Merl, Man-Yee
    FORMULARY, 2007, 42 (02) : 99 - +
  • [24] Long-acting beta2-adrenergic agonist in pediatric and adolescent asthma patients, 2003-2011
    Zhou, Esther H.
    Kang, Elizabeth M.
    Seymour, Sally
    Iyasu, Solomon
    JOURNAL OF ASTHMA, 2014, 51 (10) : 1061 - 1067
  • [25] The role of inhaled long-acting beta-2 agonists in the management of asthma
    Kelly, HW
    Harkins, MS
    Boushey, H
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (01) : 8 - 16
  • [26] Cessation of long-acting β2-agonist in children with persistent asthma on inhaled corticosteroids
    Ducharme, Francine M.
    Gagnon, Roxanne
    Benard, Brigitte
    Tse, Sze Man
    Thivierge, Robert
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (02) : 558 - 560
  • [27] Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step Down to Mometasone Monotherapy
    Weinstein, Cindy L. J.
    Ryan, Nicholas
    Zhang, Xiaoli
    Shekar, Tulin
    Gates, Davis
    Lane, Stephen J.
    Agache, Ioana
    Nathan, Robert A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (05): : 1634 - +
  • [28] Treatment of Persistent Asthma With Symbicort® (Budesonide/Formoterol Inhalation Aerosol): An Inhaled Corticosteroid and Long-Acting β2-Adrenergic Agonist in One Pressurized Metered-Dose Inhaler
    Berger, William E.
    Noonan, Michael J.
    JOURNAL OF ASTHMA, 2010, 47 (04) : 447 - 459
  • [29] An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta(2)-agonist
    Yates, DH
    Kharitonov, SA
    Barnes, PJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (06) : 1603 - 1607
  • [30] Acute relief of exercise-induced bronchoconstriction by inhaled formoterol in children with persistent asthma
    Hermansen, Mette Northman
    Nielsen, Kim Gjerum
    Buchvald, Frederik
    Jespersen, Jakob Jessing
    Bengtsson, Thomas
    Bisgaard, Hans
    CHEST, 2006, 129 (05) : 1203 - 1209
12345